1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1
- 2017
- Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy
- Characterization of a novel monoclonal antibody targeting epitope II within hepatitis C virus E2 envelope glycoprotein
- A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
- Development and characterization of a human monoclonal antibody for prevention of HCV recurrence in liver transplant patients
- 2016
- Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge
- Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
- 2015
- A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver
- 2012
- A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo
- 2011
- In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus